Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended pegylated interferon alfa-2a therapy in Chinese patients with HBeAg-negative chronic hepatitis B
ChiCTR-TRC-12002970Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: HBsAg suppression rate. Started Jun 2008; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-12002970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002970.